PYC pyc therapeutics limited

Ann: 2019 AGM Presentation, page-40

  1. 5,468 Posts.
    lightbulb Created with Sketch. 703
    Here is some info on zolgensma, the drug that is apparently putting a dent in spinraza sales. Another gene therapy now most expensive ever. Interesting though that they claim it is a once off application that effectively fixes the issue permanently.

    https://www.npr.org/sections/health-shots/2019/05/24/725404168/at-2-125-million-new-gene-therapy-is-the-most-expensive-drug-ever

    Novartis set the price at $2.125 million but offers insurers the ability to pay $425,000 a year for five years. This price tag makes Zolgensma the most expensive drug ever approved.


    The drug is delivered as a single one-time dose to address the genetic root cause of the disorder, the company says, producing long-term effects.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
0.000(0.00%)
Mkt cap ! $676.5M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 20403 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.18 1117 1
View Market Depth
Last trade - 10.09am 17/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.